{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["17(4)"],"submitter":["Tanaka A"],"funding":["Teijin Pharma Limited, Japan"],"journal":["PLoS medicine"],"pagination":["e1003095"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7176100"],"repository":["biostudies-literature"],"pubmed_title":["Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial."],"pmcid":["PMC7176100"],"pubmed_authors":["Teragawa H","Taguchi I","Eguchi K","Ishizu T","PRIZE study investigators","Ohishi M","Sata M","Node K","Tanaka A","Ueda S","Yamada H","Tomiyama H","Kato T","Maemura K","Kanzaki Y","Sezai A","Yokote K","Higashi Y","Oyama JI","Ishibashi R","Ishizaka N","Toyoda S","Murohara T","Kario K"],"additional_accession":[]},"is_claimable":false,"name":"Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial.","description":null,"dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Apr","modification":"2025-04-22T09:20:41.774Z","creation":"2025-04-05T22:58:23.346Z"},"accession":"S-EPMC7176100","cross_references":{"pubmed":["32320401"],"doi":["10.1371/journal.pmed.1003095"]}}